Cutler Scott 4

What Happened Scott Cutler, President & CEO and a director of HealthEquity, was granted 72,754 restricted stock units (RSUs) on March 25, 2026 (transaction coded "A" — award/grant). The grant price is $0.00 and the reported acquisition value is $0. This is a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-25; Form 4 filed: 2026-03-27 (appears timely).
• Grant: 72,754 RSUs; grant price reported $0.00; aggregate value reported $0 at grant.
• Shares owned after transaction: Not specified in this filing.
• Vesting (footnote): Each RSU converts to one share. 25% vests on April 1, 2027, then 6.25% vests on the first day of each calendar quarter for the 12 quarters following April 1, 2027 (fully vests over that schedule).
• Administrative note: A Power of Attorney for Mr. Cutler previously filed with the SEC (Jan 10, 2025) is incorporated by reference.

Context RSUs are a form of equity compensation that give the holder the right to receive shares in the future if vesting conditions are met; no shares changed hands on the grant date and no cash was paid. Such awards are common for executives as part of pay packages — they are informational about compensation but do not by themselves indicate immediate insider buying or selling activity.